A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...
The U.S. Food and Drug Administration on Thursday announced the names of nine products, under a new fast-track review process ...
The Priority Review program is a new initiative launched by the current administration. It was first announced in June of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback